← Leaderboards
Agneta Von Gegerfelt
University Of Miami School Of Medicine
$473,715
Attributed
$473,715
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $113.3K · FY2013–17$200K$150K$100K$50K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$473,715 · 1
By mechanism
P01$473,715 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- W. Dalton Dalton Dietrich$19,442,320
- Gennaro D'urso$1,681,021
- Nima Sharifi$12,617,877
- Savita Pahwa$35,297,534
- Mary Bartlett Bunge$3,702,410
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1AdministratorAgreementAntiviral AgentsAttenuatedCell LineCellsAnalogCommunicable DiseasesCommunicationData ExchangeDefective VirusesDesignDoctor Of PhilosophyDrug DiscoveryDrug KineticsCellular TargetingEnsureEvaluationExerciseExhibitsFundingGrantIndustry
Grant awards (5)
Preclinical Development of HIV-1 Vif Antagonists - Core B$86,115
P01 · FY2017 · MH · contact PI
Preclinical Development of HIV-1 Vif Antagonists - Core B$88,461
P01 · FY2016 · MH · contact PI
Preclinical Development of HIV-1 Vif Antagonists - Core B$90,938
P01 · FY2015 · MH · contact PI
Preclinical Development of HIV-1 Vif Antagonists - Core B$94,908
P01 · FY2014 · MH · contact PI
Preclinical Development of HIV-1 Vif Antagonists$113,293
P01 · FY2013 · MH · contact PI